These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 19376755)

  • 81. [Neonatal screening of hemoglobinopathies and glucose-6-phosphate dehydrogenase in Catalonia. Pilot study in anonymous not related population].
    Mañú-Pereira Mdel M; Maya A; Cararach V; Sabrià J; Boixadera J; Quintó L; Vives-Corrons JL
    Med Clin (Barc); 2006 Mar; 126(8):281-5. PubMed ID: 16527153
    [TBL] [Abstract][Full Text] [Related]  

  • 82. In the absence of neonatal screening facilities for sickle cell anaemia.
    Emodi I
    Ann Trop Paediatr; 2000 Mar; 20(1):77-8. PubMed ID: 10824220
    [No Abstract]   [Full Text] [Related]  

  • 83. Feasibility and acceptability of early infant screening for sickle cell disease in Lagos, Nigeria-A pilot study.
    Oluwole EO; Adeyemo TA; Osanyin GE; Odukoya OO; Kanki PJ; Afolabi BB
    PLoS One; 2020; 15(12):e0242861. PubMed ID: 33270733
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Content of communication by pediatric residents after newborn genetic screening.
    Farrell MH; La Pean A; Ladouceur L
    Pediatrics; 2005 Dec; 116(6):1492-8. PubMed ID: 16322176
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Hospitalization of children with sickle cell disease in a region with increasing immigration rates.
    Colombatti R; Dalla Pozza LV; Mazzucato M; Sainati L; Pierobon M; Facchin P
    Haematologica; 2008 Mar; 93(3):463-4. PubMed ID: 18310539
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Birth prevalence rates of newborn screening disorders in relation to screening practices in the United States.
    Hertzberg VS; Hinton CF; Therrell BL; Shapira SK
    J Pediatr; 2011 Oct; 159(4):555-60. PubMed ID: 21641615
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Updating neonatal neurometabolic screening].
    Alfonso I; Charria G
    Medicina (B Aires); 2009; 69(1 Pt 1):36-40. PubMed ID: 19240000
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Overview of newborn screening in Arkansas.
    West R; Hale C
    J Ark Med Soc; 1995 Dec; 92(7):329-33. PubMed ID: 8537290
    [No Abstract]   [Full Text] [Related]  

  • 89. Screening for congenital hypothyroidism--a new era in Bangladesh.
    Hasan M; Nahar N; Ahmed A; Moslem F
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():162-4. PubMed ID: 15906726
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The prevalence of sickle cell anemia in Saudi children and adolescents. A community-based survey.
    Al-Mendalawi MD
    Saudi Med J; 2009 Mar; 30(3):452: author reply 452. PubMed ID: 19271087
    [No Abstract]   [Full Text] [Related]  

  • 91. [Recognition of children with sickle cell disease in The Netherlands].
    Heijboer H; Van den Tweel XW; Fijnvandraat K; Peters M
    Ned Tijdschr Geneeskd; 2007 Nov; 151(45):2498-501. PubMed ID: 18062592
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Neonatal screening of sickle cell disease in France].
    Bardakdjian-Michau J
    Arch Pediatr; 2008 Jun; 15(5):738-40. PubMed ID: 18582733
    [No Abstract]   [Full Text] [Related]  

  • 93. The Prevalence of Sickle Cell Disease and Its Implication for Newborn Screening in Germany (Hamburg Metropolitan Area).
    Grosse R; Lukacs Z; Cobos PN; Oyen F; Ehmen C; Muntau B; Timmann C; Noack B
    Pediatr Blood Cancer; 2016 Jan; 63(1):168-70. PubMed ID: 26275168
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Newborn sickle cell disease screening: the Jamaican experience (1995-2006).
    King L; Fraser R; Forbes M; Grindley M; Ali S; Reid M
    J Med Screen; 2007; 14(3):117-22. PubMed ID: 17925083
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Update: newborn screening for sickle cell disease--California, Illinois, and New York, 1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Aug; 49(32):729-31. PubMed ID: 11411826
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [The advisory report 'Neonatal screening' from the Health Council of The Netherlands].
    Bolhuis PA; Page-Christiaens GC
    Ned Tijdschr Geneeskd; 2005 Dec; 149(51):2857-60. PubMed ID: 16398167
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Newborn screening by tandem mass spectrometry confirms the high prevalence of sickle cell disease among German newborns.
    Lobitz S; Klein J; Brose A; Blankenstein O; Frömmel C
    Ann Hematol; 2019 Jan; 98(1):47-53. PubMed ID: 30132072
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Newborn screening for sickle cell disorders using tandem mass spectrometry: three years' experience of using a protocol to detect only the disease states.
    Moat SJ; Rees D; George RS; King L; Dodd A; Ifederu A; Ramgoolam T; Hillier S
    Ann Clin Biochem; 2017 Sep; 54(5):601-611. PubMed ID: 28656815
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Newborn metabolic screening and related pitfalls.
    Eddy M; Gottesman GS
    Mo Med; 2009; 106(3):234-40. PubMed ID: 22641920
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The prevalence of sickle cell trait in Sierra Leone. A laboratory profile.
    Wurie AT; Wurie IM; Gevao SM; Robbin-Coker DJ
    West Afr J Med; 1996; 15(4):201-3. PubMed ID: 9020596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.